Billiontoone company information, Employees & Contact Information

BillionToOne Expands Executive Team to Support Growth of UNITY and Northstar Platforms PR Newswire

/C O R R E C T I O N — BillionToOne/ Morningstar

BillionToOne Reports Over 100% Growth in Revenue Year-Over-Year PR Newswire

BillionToOne Expands Executive Team with Dr. Haywood Brown as Chief Medical Officer, Prenatal PR Newswire

BillionToOne Celebrates Major Milestone: 1 Million UNITY Tests Yahoo Finance

BillionToOne to Present New Data at AACR Annual Meeting 2025 PR Newswire

Leading Molecular Diagnostics Company BillionToOne Announces Three Executive Appointments Amid Rapid Growth PR Newswire

BillionToOne's Northstar Select® Demonstrates Superior Sensitivity in Prospective Head-to-Head Validation Study Publication PR Newswire

Leading Molecular Diagnostics Company BillionToOne Raises $130 Million in Oversubscribed Series D Funding Over $1B+ Valuation PR Newswire

BillionToOne Launches Expanded Panel for UNITY Fetal Risk™ Screen, Setting New Standard in Prenatal Testing PR Newswire

BillionToOne, Inc., announced today that it has closed its follow-on Series A+ funding round of $15 million PR Newswire

Category Defining Molecular Diagnostics Company BillionToOne Further Solidifies its Long-Term Position by Securing $140 Million Non-Dilutive Financing with Oberland Capital PR Newswire

BillionToOne to Present at the 42nd Annual J.P. Morgan Healthcare Conference PR Newswire

BillionToOne Announces Medicare Coverage for Northstar Select® PR Newswire

BillionToOne Announces Green Journal Publication that Underscores the Role of cell-free DNA NIPT for Fetal Red Blood Cell Antigen Genotyping PR Newswire

BillionToOne's UNITY Fetal Antigen NIPT Transforms Care in Maternity Health Deserts PR Newswire

BillionToOne Announces $48.5M Additional Capital Raise and $35M Upsized Term Loan Facility, Demonstrating Investor and Lender Confidence in the Company's Rapid Growth PR Newswire

BLLN IPO News - Molecular diagnostics company BillionToOne files for a $100 million IPO renaissancecapital.com

New Study Showed Unnecessary Burden From Continued Monitoring of Alloimmunized Pregnancies With Antigen-Negative Fetuses PR Newswire

BillionToOne Closes $125M Series C Funding with Premier Global Investors PR Newswire

BILLIONTOONE ANNOUNCES ROSS TAYLOR AS CHIEF FINANCIAL OFFICER PR Newswire

BILLIONTOONE MITIGATING RHOGAM(R) SHORTAGE WITH UNITY FETAL RhD™ NON-INVASIVE PRENATAL TEST PR Newswire

BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% Accuracy Newswire.com

BillionToOne Announces Global Collaboration to Provide its UNITY Fetal Antigen™ Clinical Trial Assay in Johnson & Johnson Phase 3 Clinical Trial of Nipocalimab in Hemolytic Disease of the Fetus and Newborn PR Newswire

BillionToOne Appoints Nipun Soni, CFA, CPA as the First Chief Financial Officer Newswire.com

BillionToOne's Senior Vice President of Sales and Commercial Operations Named One of the Top 25 Women Leaders in Biotechnology of 2021 Newswire.com

BillionToOne Announces Clinical Outcomes Data for UNITY Fetal Risk™ Screen, Demonstrating Exceptional Accuracy in General Pregnancy Population PR Newswire

BillionToOne launches oncology liquid biopsy products for research use & announces clinical research collaboration with UCSD PR Newswire

BillionToOne Closes $55M Series B Funding, Builds Out a 36,000 Sqft Space to Meet Growing Demand Newswire.com

Reflex single-gene non-invasive prenatal testing significantly increases the cost-effectiveness of carrier screening medRxiv

BillionToOne Launches Novel Fetal Antigen NIPT as Part of UNITY Screen™ to Help Streamline Management of Pregnant Patients Who Are Alloimmunized PR Newswire

New life science facility breaks ground in East Austin; 1,000 new jobs anticipated Community Impact | News

Reflex single-gene non-invasive prenatal test significantly increases the cost-effectiveness of carrier screening medRxiv

$1B development EastVillage brings work, life, play to northeast corridor Community Impact | News

Validation of a Non-invasive Prenatal Test for Fetal RhD, C, c, E, Kell and FyA Antigens medRxiv

BillionToOne announces groundbreaking new COVID-19 test to unlock 1 million daily tests PharmiWeb.com

BillionToOne launches UNITY™ prenatal screen PR Newswire

NIPT (Non-Invasive Prenatal Testing) | Clinical OMICs Mary Ann Liebert, Inc.

BillionToOne, Inc. Plans $199.99 million IPO for November 6th (BLLN) Defense World